Synthesis and antitumor activity evaluation of some N-heterocycles derived from pyrazolyl-substituted 2(3H)-furanone

References

• Abou-Elmagd, W. S. I.; Hashem, A. I. Synthesis and antitumor activity evaluation of some novel fused and spiro heterocycles derived from a 2(3H)-furanone derivative. J. Heterocycl. Chem. 2016, 53, 202.
   Web of Science ®Google Scholar
• Shivarama, H. B.; Narayana, P. K.; Sooryanarayana, R. B.; Shivananda, M. K. New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur. J. Med. Chem. 2002, 3, 511.
   Google Scholar
• Todoulou, O. G.; Papadaki-Valiraki, A. E.; Ikeda, S.; De Clercq, E. Synthesis and antiviral activity of some new 1H-1,2,4-triazole derivatives. Eur. J. Med. Chem. 1994, 29, 611.
   Web of Science ®Google Scholar
• Bu, X.; Chen, J.; Deady, W. L.; Denny, W. A. Synthesis and cytotoxicity of potential anticancer derivatives of pyrazolo[3,4,5-kl]acridine and indolo[2,3-a] acridine. Tetrahedron 2002, 58, 175.
   Web of Science ®Google Scholar
• Ohki, H.; Hirotani, K.; Naito, H.; Ohsuki, S.; Minami, M.; Ejima, A. Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity. Bioorg. Med. Chem. Lett. 2002, 12, 3191.
   PubMed Web of Science ®Google Scholar
• Xia, Y.; Dong, Z. W.; Zhao, B. X.; Ge, X.; Meng, N.; Shin, D. S. Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Bioorg. Med. Chem. 2007, 15, 6893.
   PubMed Web of Science ®Google Scholar
• Zhang, J. H.; Fan, C. D.; Zhao, B. X.; Shin, D. S. Dong, W. L.; Xie, Y. S. Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells. Bioorg. Med. Chem. 2008, 16, 10165.
   PubMed Web of Science ®Google Scholar
• Zheng, L. W.; Zhu, J.; Zhao, B. X.; Huang, Y. H.; Ding, J.; Miao, J. Y. Synthesis, crystal structure, and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives. Eur. J. Med. Chem. 2010, 45, 5792.
   PubMed Web of Science ®Google Scholar
• Zheng, L. W.; Li, Y.; Geb, D.; Zhao, B. X.; Liu, Y. R.; Lv, H. S. Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Bioorg. Med. Chem. Lett. 2010, 20, 4766.
   PubMed Web of Science ®Google Scholar
• Ding, X. L.; Zhang, H. Y.; Qi, L., Zhao, B. X.; Lian, S.; Lv, H. S. Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Bioorg. Med. Chem. Lett. 2009, 19, 5325.
   PubMed Web of Science ®Google Scholar
• Lian, S.; Su, H.; Zhao, B. X.; Liu, W. Y.; Zheng, L. W.; Miao, J. Y. Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Bioorg. Med. Chem. 2009, 17, 7085.
   PubMed Web of Science ®Google Scholar
• Xu, Y.; Guo, Q. Syntheses of heterocyclic compounds under microwave irradiation. Heterocycles 2004, 63, 903.
   Web of Science ®Google Scholar
• Kirsch, G.; Hesse, S.; Comel, A. Synthesis of five- and six-membered heterocycles through palladium-catalyzed reactions. Curr. Org. Chem. 2004, 1, 47.
   Web of Science ®Google Scholar
• Zheng, L. W.; Shao, J. H.; Zhao, B. X.; Miao, J. Y. Synthesis of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives and their inhibition against growth of A549 and H322 lung cancer cells. Med. Chem. Lett. 2011, 21, 3909.
   PubMed Web of Science ®Google Scholar
• Hansen, J. D.; Grina, J.; Newhouse, B.; Welch, M.; Topalov, G.; Littman, N.; Callejo, M.; Gloor, S.; Martinson, M.; Laird, E.; Brandhuber, B. J.; Vigers, G.; Morales, T.; Woessner, R.; Randolph, N.; Lyssikatos, J.; Olivero, A. Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorg. Med. Chem. Lett. 2008, 18, 4692.
   PubMed Web of Science ®Google Scholar
• Newhouse, B. J.; Hansen, J. D.; Grina, J.; Welch, M.; Topalov, G.; Littman, N.; Callejo, M.; Martinson, M.; Galbraith, S.; Laird, E. R.; Brandhuberm, B. J.; Vigers, G.; Morales, T.; Woessner, R.; Randolph, N.; Lyssikatos, J.; Olivero, A. Non-oxime pyrazole-based inhibitors of B-Raf kinase. Bioorg. Med. Chem. Lett. 2011, 21, 3488.
   PubMed Web of Science ®Google Scholar
• Choi, W. K.; El-Gamal, M. I.; Choi, H. S.; Baek, D.; Oh, C. H. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies. Eur. J. Med. Chem. 2011, 46, 5754.
   PubMed Web of Science ®Google Scholar
• Kim, M. H.; Kim, M.; Yu, H.; Kim, H.; Yoo, K. H.; Sim, T.; Hah, J. M. Structure-based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells. Bioorg. Med. Chem. 2011, 19(6),1915.
   Web of Science ®Google Scholar
• Hashem, A. I.; Youssef, A. S. A.; Kandeel, K. A.; Abou-Elmagd, W. S. I. Conversion of some 2(3H)-furanones bearing a pyrazolyl group into other heterocyclic systems with a study of their antiviral activity. Eur. J. Med. Chem. 2007, 42, 934.
   PubMed Web of Science ®Google Scholar
• Sayed, H. H.; Hashem, A. I.; Youssef, N. M.; El-Sayed, W. A. Conversion of 3-arylazo-5-phenyl-2(3H)-furanone into other heterocycles of anticipated biological activity. Arch. Pharm. Chem. 2007, 340, 315.
   Web of Science ®Google Scholar
• El-kousy, S. M.; El-Torgoman, A. M.; EL-Bassiouny, A. A.; Hashem, A. I. Synthesis and reactions of some β,δ-butenolides with study of biological activity of the resulting products. Pharmazie 1988, 43(2), 80..
   PubMed Web of Science ®Google Scholar
• Hashem, A. I.; Shaban, M. E. Preparation and reactions of some derivatives of acrylic acid hydrazides and amides. J. Park. Chem. 1981, 23, 164.
   Google Scholar
• Abou-Elmagd, W. S. I.; Hashem, A. I. Conversion of some 2(3H)-furanones into pyrrolinotriazine and oxazolopyrimidine derivatives. J. Heterocycl. Chem. 2012, 49, 947.
   Web of Science ®Google Scholar
• Abou-Elmagd, W. S. I.; Hashem, A. I. Novel synthesis of some isatin hydrazones and pyridazinophthalazines. Synth. Commun. 2013, 43, 1083.
   Web of Science ®Google Scholar
• Abou-Elmagd, W. S. I.; Hashem, A. I. Synthesis of 1-amidoalkyl-2-naphthols and oxazine derivatives with study of their antibacterial and antiviral activities. Med. Chem. Res. 2013, 22, 2005.
   Web of Science ®Google Scholar
• Abou-Elmagd, W. S. I.; El-Ziaty, A. K.; Abdalha, A. A. Ring transformation and antimicrobial activity of indolyl-substituted 2(3H)-furanones. Heterocycl. Commun. 2015, 21(3), 179.
   Web of Science ®Google Scholar
• Kandeel, K. A.; Yossef, A. S.; Abou-Elmagd, W. S. I.; Hashem, A. I. Behavior of 3-benzylamino-5-aryl-2(3H)-furanones towards some nitrogen nucleophiles. J. Heterocycl. Chem. 2006, 43, 957.
   Web of Science ®Google Scholar
• Derbala, H. A.; Hamad, A. S.; El-Sayed, W. A.; Hashem, A. I. Conversion of 3-aryl-5-phenyl-2(3H)-furanones into 3(2H)-isothiazolone derivatives. Phosphorus, Sulfur Silicon Relat. Elem. 2001, 175, 153.
   Web of Science ®Google Scholar
• Hamad, A. S.; Hashem, A. I. A facile method for the synthesis of 6-aryl-1-(3- chloropropanoyl)-4-[(E)-1-(2-furyl)]methylidine]-1,2,3,4,-tetrahydropyridazinones and 2- chloroethyl)-5-[α-aracyl-β-(2-furyl)-E-vinyl-1,3,4-oxadiazoles. Molecules, 2000, 5, 895.
   Web of Science ®Google Scholar
• Hamad, A. S.; Hashem, A. I. Novel synthesis of N-[6-aryl-4-(E)-2-furylmethylene-1,2,3,4-terrahydro-3-oxopyridazin-1-yl carbonyl]-p-toluenesulfonamides and N-[5-(E)-1-aroylmethyl-2-(2-furyl) vinyl]- 1,3,4- oxadiazol-2-yl]-p-toluenesulphonamides. J. Heterocycl. Chem. 2002, 39, 1325.
   Web of Science ®Google Scholar
• Yassin, S. Abdel-Aleem, H. A.; El-sayed, I. E.; Hashem, A. I. Conversion of 1-(α -aracyl-β-(thienyl)acroyl semicarbazides into 1,2,4-triazole derivatives. Rev. Roum. Chim., 1996, 41, 989.
   Web of Science ®Google Scholar
• El-kafrawy, A. F.; Yosseef, A. S.; Hamad, A. S.; Hashem, A. I. Synthesis and reactions of some semicarbazides bearing a furane nucleus. Egypt. J. Pharm. Sci. 1993, 34, 159.
   Google Scholar
• Molecular Operating Environment (MOE), V. (2008). 10, Chemical Computing Group Inc., Montreal, Quebec, Canada.
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol Methods. 1983, 65, 55–63.
   PubMed Web of Science ®Google Scholar
• Thabrew, M. I.; Hughes, R. D.; McFarlane, I. G. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J. Pharm Pharmacol. 1997, 49, 1132–1135.
   PubMed Web of Science ®Google Scholar
• El-Menshawi, B. S.; Fayad, W.; Mahmoud, K.; El-Hallouty, S. M.; El-Manawaty, M.; Hägg Olofsson, M.; Linder, S. Screening of natural products for therapeutic activity against solid tumors. Indian J. Exp. Biol. 2010, 48, 258–264.
   PubMed Web of Science ®Google Scholar
• Tacar, O.; Sriamornsak, P.; Dass, C. R. Doxorubicin: An update on anticancer molecular action, toxicity, and novel drug delivery systems. JPP 2013, 65(2), 157–170.
   Web of Science ®Google Scholar